$0.189
+0.022 (+11.90%)At close
- High
- 0.190
- Open
- 0.171
- VWAP
- 0.18
- Volume
- 614.49K
- Mkt Cap
- —
- Low
- 0.169
- Amount
- 112.29K
- EV/EBITDA, TTM
- 0.00
Endovia Health Sciences, Inc., formerly Splash Beverage Group, Inc. seeks to identify, acquire, and build early stage or under-valued beverage brands that have growth potential within its distribution system. The Company’s distribution system is comprehensive in the United States and is expanding to select international markets. Through its division Qplash, Splash’s distribution reach includes e-commerce access to both business-to-business (B2B) and business-to-consumer (B2C) customers. It markets beverage brands to customers throughout the United States that prefer delivery direct to their office, facilities, or homes. Its segments include Splash Beverage Group and E-Commerce. The Company's Splash Beverage Group segment includes the manufacture and distribution of non-alcoholic and alcoholic branded beverages. The E-commerce segment is engaged in the sale of e-commerce beverages. Its brands include Copa di Vino single-serve wine, Pulpoloco Sangria, SALT Tequila, and Chispo Tequila.
AI analysis of Splash Beverage Group, Inc. (EDVA)
HoldEndovia Health Sciences, Inc. (EDVA) is currently trading at $0.19, which is significantly below its 52-week high of $0.47, indicating potential upside. However, the company has a troubling financial performance, with a gross margin of 43.75% in the most recent quarter but a negative net income of -2.20 per share. The RSI is at 68.838, suggesting it may be overbought. Given the high volatility and significant year-to-date decline of 59.92%, it may be wise to hold rather than buy at this moment.
Valuation Metrics
Events Timeline
News
EDVA FAQ — answered by Alphio AI
Endovia Health Sciences, Inc., formerly Splash Beverage Group, Inc. seeks to identify, acquire, and build early stage or under-valued beverage brands that have growth potential within its distribution system. The Company’s distribution system is comprehensive in the United States and is expanding to select international markets. Through its division Qplash, Splash’s distribution reach includes e-commerce access to both business-to-business (B2B) and business-to-consumer (B2C) customers. It markets beverage brands to customers throughout the United States that prefer delivery direct to their office, facilities, or homes. Its segments include Splash Beverage Group and E-Commerce. The Company's Splash Beverage Group segment includes the manufacture and distribution of non-alcoholic and alcoholic branded beverages. The E-commerce segment is engaged in the sale of e-commerce beverages. Its brands include Copa di Vino single-serve wine, Pulpoloco Sangria, SALT Tequila, and Chispo Tequila.
Endovia Health Sciences, Inc. (EDVA) is currently trading at $0.19, which is significantly below its 52-week high of $0.47, indicating potential upside. However, the company has a troubling financial performance, with a gross margin of 43.75% in the most recent quarter but a negative net income of -2.20 per share. The RSI is at 68.838, suggesting it may be overbought. Given the high volatility and significant year-to-date decline of 59.92%, it may be wise to hold rather than buy at this moment.
Community
More ↗No posts yet
Sign up or log in to join the discussionRelated articles
- CPI Report and the Stock Market: How to Read October 2026 Inflation Data Before the Fed DecidesOctober 2026 CPI lands Nov 10 with no year-over-year number and Fed hike odds near 80%. Learn how to read CPI, which stocks react, and how to plan for it.
- Are You Buying NVIDIA’s Earnings or Its CEO’s Perfect Image?An Alphio analysis of NVIDIA’s share-price timeline, operating results, governance uncertainty and upcoming earnings.
- Stock Market After the 2026 Midterms: What a Democratic Congress Means for InvestorsDemocrats swept Congress in the 2026 midterms. See how stocks reacted, what history says about post-midterm returns, and which sectors face new risks.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.
